Burning Rock Biotech Limited American Depositary Shares

BNR XNAS

Market Cap

100M

Short interest (May 15)

0.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

4.94%

↓ 1.2%

Available Shares

400K

↑ 9.1%

Price Chart

Company Overview

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Company Info

Exchange: NASDAQ
CIK: 0001792267
Asset Type: ADRC

Market Data

Market Cap: $101,666,746
Employees: 667
Status: Active

Short Interest

Current Borrow Fee 4.94%
Range: 3.24% - 5.32%
Available Shares 400K
Range: 350K - 400K

Recent Changes

Fee Change: ↓ 16.5%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime